Literature DB >> 14211862

IATROGENIC BRONCHOSPASM OCCURRING DURING CLINICAL TRIALS OF A NEW MUCOLYTIC AGENT, ACETYLCYSTEINE.

I L BERNSTEIN, R W AUSDENMOORE.   

Abstract

Entities:  

Keywords:  ACETYLCYSTEINE; AEROSOLS; ASTHMA; BRONCHIAL SPASM; CYSTEINE; DRUG THERAPY; IATROGENIC DISEASE; TOXICOLOGIC REPORT

Mesh：

Substances：

Year:  1964        PMID： 14211862     DOI： 10.1378/chest.46.4.469

Source DB:  PubMed          Journal:  Dis Chest        ISSN： 0096-0217


× No keyword cloud information.
  5 in total

1.  Rheological assessment of mucolytic agents on sputum of chronic bronchitics.

Authors:  J E Dippy; S S Davis
Journal:  Thorax       Date:  1969-11       Impact factor: 9.139

2.  The effects of direct instillations of a therapeutic mixture into the tracheobronchial tree.

Authors:  P N Paez; M Mansangkay; B J Sproule
Journal:  Can Med Assoc J       Date:  1966-09-03       Impact factor: 8.262

3.  Mucolytic agent.

Authors: 
Journal:  Br Med J       Date:  1966-09-10

4.  Clinical and physiological evaluation of mucolytic agents nebulized with soproterenol: 10 per cent N-acetylcysteine verus 10 per cent 2-mercaptoethane sulphonate.

Authors:  S R Hirsch; P F Viernes; R C Kory
Journal:  Thorax       Date:  1970-11       Impact factor: 9.139

5.  Preventive nebulization of mucolytic agents and bronchodilating drugs in invasively ventilated intensive care unit patients (NEBULAE): study protocol for a randomized controlled trial.

Authors:  Sophia M van der Hoeven; Jan M Binnekade; Corianne A J M de Borgie; Frank H Bosch; Henrik Endeman; Janneke Horn; Nicole P Juffermans; Nardo J M van der Meer; Maruschka P Merkus; Hazra S Moeniralam; Bart van Silfhout; Mathilde Slabbekoorn; Willemke Stilma; Jan Willem Wijnhoven; Marcus J Schultz; Frederique Paulus
Journal:  Trials       Date:  2015-09-02       Impact factor: 2.279
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.